A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer

BACKGROUND: Gene expression profiling (GEP)-based prognostic signatures are being rapidly integrated into clinical decision making for systemic management of breast cancer patients. However, GEP remains relatively underdeveloped for locoregional risk assessment. Yet, locoregional recurrence (LRR), e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiodoni, C., Sangaletti, S., Lecchi, M., Ciniselli, C.M., Cancila, V., Tripodi, I., Ratti, C., Talarico, G., Brich, S., De Cecco, L., Baili, P., Truffi, M., Sottotetti, F., Piccotti, F., Tripodo, C., Pruneri, G., Triulzi, T., Corsi, F., Cappelletti, V., Di Cosimo, S., Verderio, P., Colombo, M.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485389/
https://www.ncbi.nlm.nih.gov/pubmed/37393630
http://dx.doi.org/10.1016/j.esmoop.2023.101590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485389/
https://www.ncbi.nlm.nih.gov/pubmed/37393630
http://dx.doi.org/10.1016/j.esmoop.2023.101590

Ejemplares similares